EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Biomimetic Apatite Nanoparticles and Microcrystalline Tyrosine as Biocompatible Vaccine Adjuvants: Performance in a Bluetongue Virus Sheep Model

Estela Pérez iD, Víctor Sebastián, Ana Rodríguez-Largo, Ricardo de Miguel, Álex Gómez, Matthias F Kramer, Anke Graessel, Belén Parra-Torrejón, José Manuel Delgado-López, Sergio Utrilla-Trigo, Luis Jiménez-Cabello, Javier Ortego und 4 weitere

ACS Applied Materials & Interfaces · 2025

DOI: 10.1021/acsami.5c10402 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, 2025. Verfasst von Estela Pérez und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Animal Pathology, University of Zaragoza, 177 Miguel Servet Street, Zaragoza 50013, Spain. Hauptthemen laut MEDLINE: Nanoparticles, Bluetongue virus, Bluetongue, Apatites. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministerio de Ciencia, Innovaci?n y Universidades, Agencia Estatal de Investigaci?n.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aluminum oxyhydroxide (AlOOH) is the most widely used vaccine adjuvant, but its known adverse effects prompt the finding of other, safer alternative adjuvants. This study compares in sheep the global performance and safety of vaccine prototypes against bluetongue virus (BTV) formulated with AlOOH, biomimetic apatite nanoparticles (ApNPs), and microcrystalline tyrosine (MCT). Five groups of 6 sheep were included in the study: control, BTV serotype 4 alone, and BTV-4 combined either with AlOOH, ApNPs, or MCT. Adjuvants were fully characterized. Group specific antibodies against BTV-4 were observed in all treatment groups, including BTV-4 alone. After booster inoculation, ApNPs or MCT groups responded immediately, and it was delayed for BTV-4 and AlOOH groups. Comparable neutralizing antibody responses were observed in all treatment groups but were earlier for BTV-4, ApNPs, and MCT groups when compared with the AlOOH group. No significant systemic alterations were observed during the study. The AlOOH group developed more pronounced local reactions that persisted throughout the 133-day study and were evident as post-mortem granulomas. ApNPs and MCT are biocompatible, safer, and viable alternative adjuvants for sheep vaccines. BTV alone might also be suitable for this purpose. This work is the first demonstrating the suitability of biocompatible alternative adjuvants in sheep vaccines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesBluetongue virusBluetongueApatitesTyrosineViral VaccinesBiomimetic MaterialsAdjuvants, VaccineAdjuvants, ImmunologicAnimalsSheepBiocompatible MaterialsDisease Models, Animal

Stichwörter der Autor:innen

aluminum oxyhydroxide adjuvantbiomimetic apatite nanoparticlesbluetongue virusmicrocrystalline tyrosineovine modelsheepvaccine

Substanzen

ApatitesTyrosineViral VaccinesAdjuvants, VaccineAdjuvants, ImmunologicBiocompatible Materials

Autor:innen und Institutionen

  • Department of Animal Pathology, University of Zaragoza, 177 Miguel Servet Street, Zaragoza 50013, Spain.
  • Institute of Nanoscience and Materials of Aragon (INMA), CSIC-University of Zaragoza, Mariano Esquillor Gómez Street I+D+i building, Zaragoza 50018, Spain.
  • Department of Chemical and Environmental Engineering, University of Zaragoza, María de Luna 3 Street, Zaragoza 50018, Spain.
  • Advanced Microscopy Laboratory, University of Zaragoza, Mariano Esquillor Gómez Street I+D+i building, Zaragoza 50018, Spain.
  • Agri-Food Institute of Aragon (IA2), University of Zaragoza, 177 Miguel Servet Street, Zaragoza 50013, Spain.
  • Bencard Adjuvant Systems, Allergy Therapeutics PLC, Dominion Way Street, Worthing BN14 8SA, U.K.

ORCID-Profile: Estela Pérez, Ignacio de Blas, Lluís Luján

Förderung

  • Ministerio de Ciencia, Innovaci?n y Universidades
  • Agencia Estatal de Investigaci?n

Zitieren

APA

Pérez, E., Sebastián, V., Rodríguez-Largo, A., de Miguel, R., Gómez, Á., Kramer, M. F., Graessel, A., Parra-Torrejón, B., Delgado-López, J. M., Utrilla-Trigo, S., Jiménez-Cabello, L., Ortego, J., de Blas, I., Reina, R., Pérez, M., & Luján, L. (2025). Biomimetic Apatite Nanoparticles and Microcrystalline Tyrosine as Biocompatible Vaccine Adjuvants: Performance in a Bluetongue Virus Sheep Model. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.5c10402

Vancouver

Pérez E, Sebastián V, Rodríguez-Largo A, de Miguel R, Gómez Á, Kramer MF, et al. Biomimetic Apatite Nanoparticles and Microcrystalline Tyrosine as Biocompatible Vaccine Adjuvants: Performance in a Bluetongue Virus Sheep Model. ACS Applied Materials & Interfaces. 2025. doi:10.1021/acsami.5c10402

BibTeX
@article{Prez2025,
  author = {Pérez, Estela and Sebastián, Víctor and Rodríguez-Largo, Ana and de Miguel, Ricardo and Gómez, Álex and Kramer, Matthias F and Graessel, Anke and Parra-Torrejón, Belén and Delgado-López, José Manuel and Utrilla-Trigo, Sergio and Jiménez-Cabello, Luis and Ortego, Javier and de Blas, Ignacio and Reina, Ramsés and Pérez, Marta and Luján, Lluís},
  title = {Biomimetic Apatite Nanoparticles and Microcrystalline Tyrosine as Biocompatible Vaccine Adjuvants: Performance in a Bluetongue Virus Sheep Model},
  journal = {ACS Applied Materials & Interfaces},
  year = {2025},
  doi = {10.1021/acsami.5c10402}
}
Kostenlos starten →